Allergic emergencies

Incidence and characteristics of biphasic and protracted anaphylaxis: evaluation of 114 inpatients

Aim

Anaphylaxis is a systemic allergic reaction that potentially causes death. Most anaphylactic reactions are uniphasic, but some cases may be biphasic or protracted. However, these clinical epidemiology concepts are unfamiliar in Japan. Therefore, we have investigated the incidences and characteristics of patients with biphasic and protracted anaphylaxis.

Methods

We retrospectively evaluated patients with anaphylaxis in a single emergency medical center located in Yokohama, Japan from April 2009 to March 2012. We analyzed the incidences and characteristics of patients with biphasic and protracted anaphylaxis who needed to be admitted.

Results

A total of 253 patients were diagnosed with anaphylaxis and 114 patients needed to be admitted. Of the 114 patients, 103 (90.4%) were uniphasic, 7 (6.1%) were biphasic and 4 (3.5%) were protracted anaphylaxis. The most common antigens were foods and drugs. The median onset of a biphasic reaction was 8 h and dermatologic symptoms were mostly observed. Regarding severity, mild symptoms were seen in four cases, similar symptoms to the initial reaction were seen in two cases, and only one case was severe. The duration of protracted anaphylaxis varied from 2 to 8 days.

Conclusion

The incidence of biphasic and protracted anaphylaxis in inpatients was 6.1% and 3.5%, respectively. The median onset of biphasic reaction was 8 h, and most symptoms were mild or similar to the initial reaction. We suggest that patients with anaphylaxis need an 8-h and ideally a 24-h observation period in order to monitor possible biphasic reactions. The duration of protracted anaphylaxis was up to 8 days.

Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy

Background

Lymphazurin 1% blue dye can cause a severe anaphylactic reaction in approximately 1–3% of patients.

Case presentation

We describe a case of intraoperative anaphylaxis resulting from Lymphazurin 1% blue dye. A 48-year old woman undergoing a mastectomy with sentinel lymph node biopsy experienced a biphasic anaphylactic reaction with two episodes of hypotension at 15 minutes and 2 hours, respectively, after injection of the blue dye. The late phase was initially refractory to epinephrine.

Conclusion

Early recognition, aggressive hemodynamic management, and prolonged monitoring are indicated in these patients to watch for a potential second phase anaphylactic reaction.

Forensic Lung Pathology

Sudden and unexpected natural deaths and nonnatural deaths may result from various pulmonary conditions. Additionally, several nonpulmonary conditions of forensic significance may be complicated by the development of respiratory lesions. Certain situations with pulmonary pathology are particularly likely to be critically scrutinized and may form the basis of allegations of medical negligence, other personal injury liability, or wrongful death.1

[Out-of-Hospital treatment of anaphylactoid reactions]

The term anaphylactoid reaction is a generic term used for allergic reactions with symptoms of anaphylaxis. Anaphylaxis is a severe systemic allergic reaction that is potentially fatal. It requires prompt recognition and immediate management. The syndrome can affect virtually any organ in the body, although reactions involving the respiratory, the cardiovascular, the cutaneous and the gastrointestinal systems are most common. Anaphylaxis is caused by the release of mediators from mast cells and basophiles. Reactions typically follow a uniphasic course; however, 20% will be biphasic in nature. The second phase usually occurs after an asymptomatic period of 10 hours in the mean. Adrenaline is the pharmacological treatment of choice and should be used in all patients showing signs of beginning blood pressure decrease or upper airway oedema. Further therapy in the treatment of anaphylaxis includes circulatory support, volume therapy, antihistamines and corticosteroids. Post-treatment observation of these patients is absolutely necessary. Once recovered, patients should be hospitalized and monitored for the following 24-48 hours.

Anaphylaxis: a review of causes and mechanisms

Anaphylaxis is a life-threatening syndrome resulting from the sudden release of mast cell- and basophil-derived mediators into the circulation. Foods and medications cause most anaphylaxis for which a cause can be identified, but virtually any agent capable of directly or indirectly activating mast cells or basophils can cause this syndrome. This review discusses the pathophysiologic mechanisms of anaphylaxis, its causes, and its treatment.

Management of bee-sting anaphylaxis

A retrospective case analysis of 101 adverse reactions to bee-stings and a prospective questionnaire analysis of the proposed management by local medical practitioners and resident hospital staff members of three hypothetical bee-sting reactions has revealed that understanding of the use of adrenaline in patients with reactions to bee envenomation is confused with regard to the indications for its use, dosage and route; that corticosteroid agents are used or are recommended too frequently, sometimes as the sole therapeutic agent; and that there is a lack of awareness of the need for volume replacement in hypotensive shocked patients. These conclusions highlight the urgent need for a greater understanding of the optimal forms of management for patients with acute anaphylactic reactions to bee envenomation.

Anaphylaxis

The clinical syndrome of anaphylactic shock is a disorder produced by multiple mechanisms and pharmacological and environmental factors. The syndrome may be produced by both immunologic and nonimmunologic mechanisms and is due to the release of preformed biologically active mediators and the generation of biologically active mediators. The main mediator appears to be histamine. Although there are a number of defined predisposing factors, the majority of first reactions appear unpredictably. The mainstay of treatment is the use of epinephrine, volume replacement, and positive pressure ventilation. The follow-up and documentation of details of the reaction and exhaustive efforts to determine the precipitating factor are important aspects of the subsequent safety of the patient. History may be of more value than diagnostic testing. The use of H1 and H2 blockers, with steroids and sympathomimetics, may reduce the risk or magnitude of reactions in patients with a past history of a reaction.

The therapy of anaphylactic shock

Anaphylaxis is an acute, often life-threatening systemic reaction to mediators released by basophils and mast cells. Histamine, leukotrienes, prostaglandins, and other mediators are responsible for complex and varied reactions in man. Serious cardiovascular or pulmonary involvement can lead to death within minutes. Therapy depends on prompt recognition of the disease and rapid administration of epinephrine. Even in ideal clinical settings, response to therapy may be slow and a long resuscitation necessary. Antihistamines, glucocorticoids, intravascular volume expansion, sympathomimetics, bronchodilators, and controlled ventilation all may be necessary. Taking careful allergy histories; using enteral routes for drug administration when possible; observing patients, who have received injections for at least 20 minutes; and rapidly treating patients with epinephrine are the main means of reducing the incidence and mortality of this disease.

Anaphylaxis secondary to chymopapain

Anaphylaxis occurs in approximately 1% of the patients treated with chymopapain. The incidence of anaphylaxis is ten times higher in women than in men. The severity of the reaction may be attenuated by pretreatment with H1- and H2-histamine receptor antagonist. Once anaphylaxis occurs, prompt and correct treatment must be instituted.

Anaphylaxis: pathophysiology, clinical presentations and treatment

Anaphylaxis and anaphylactoid reactions are abrupt, often life-threatening episodes, secondary to the liberation of certain chemical mediators, and their effects on target organs. The number of agents known to trigger such reactions is expanding, with the most common fatal reactions secondary to penicillins, iodinated contrast material (ICM), and hymenoptera stings. Limited studies point to upper airway obstruction and circulatory collapse as the causes of death in man. It is felt that the frequency of cardiovascular involvement is not widely appreciated, and that hypotensive patients can be markedly hypovolemic. The primary goals of treatment should be aimed at preventing or reversing complications, and include immediate attention to the airway, cardiac monitoring, and establishment of intravenous access. The cornerstone of pharmacologic therapy is epinephrine. A comprehensive review of the pathophysiology, symptomatology, and treatment is presented.

Anaphylactoid reaction to infusion of polygelatin (Haemaccel). A study in pregnant women

A series of allergic reactions to infusion of polygelatin (Haemaccel) in six pregnant women is reported. These women and a control group of five pregnant women were studied with analysis of complement, ELISA and skin tests. No differences were found between the groups in the factors studied. It is concluded that the reactions to polygelatin were caused through direct liberation of histamine, that is, an anaphylactoid reaction.

Endotracheal epinephrine in a canine anaphylactic shock model

This study was undertaken to determine if epinephrine administered endotracheally is as effective in treating anaphylactic shock as is intravenously administered epinephrine. An animal model of anaphylactic shock was produced in anesthetized dogs by the intravenous administration of histamine phosphate. Both the endotracheal and intravenous routes of epinephrine administration resulted in efficient and effective reversal of histamine-induced hypotension. At the doses employed, the intravenous administration of epinephrine resulted in the production of significantly (p less than 0.05) greater numbers of ventricular cardiac arrhythmias than did the endotracheal route of administration.

Severe histamine mediated reactions to intravenous drugs used in anaesthesia

Severe histamine mediated reactions to intravenous drugs used in anaesthesia may occur as a result of anaphylactic and anaphylactoid reactions. The incidence is rare, but appears to be increasing. The difficulties in diagnosing such reactions and in determining the drug responsible and how these difficulties have led to confusion in the literature are discussed. Six cases of severe histamine mediated reactions are presented and detailed analyses of the drugs in these and other reported reactions is made showing varied clinical patterns with different drugs. The prevention, treatment, and follow-up of severe histamine mediated reactions are considered.

Anaphylaxis manifested by hypotension alone

Three instances of life-threating adverse reations to intravenous contrast media and penicillin have been presented. Hypotension was the major presenting sign, and was prolonged and relieved only by copious dluid therapy. In 1 case the onset of hypotension was delayed for an hour. Urologists should be aware of the variety and proper treatment of drug reactions.